|Articles|October 1, 2009
- Applied Clinical Trials-10-01-2009
- Volume 0
- Issue 0
Applied Clinical Trials Digital Edition - October 2009
CRO/SPONSOR : The Value of Late-Phase Patient Reported Outcomes Financial Simulation Modeling in Clinical Trials TRIAL DESIGN : A Concise Look at Adaptive LABS : Steps to Optimize Imaging Also in this issue : New FDA Leadership Means Business, EU Works Together to Improve Trial Rules, Interoperability: A Reality or Just a Dream?, Social Media and Health Care
Advertisement
Articles in this issue
almost 17 years ago
Globalization Gets An A+almost 17 years ago
Obesity, Lipids, and Diabetesalmost 17 years ago
Late Phase Patient Reported Outcomesalmost 17 years ago
FDA Promotes Integrity and Compliancealmost 17 years ago
Pressure Mounts for ICH GCP Revisionsalmost 17 years ago
Business and People Update October 2009almost 17 years ago
The Semantics of Health Care Interoperabilityalmost 17 years ago
Operation Adaptivealmost 17 years ago
Financial Simulation Modelingalmost 17 years ago
Working Toward a Better FutureAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
From Participation to Understanding: Reframing Engagement in Clinical Trials
2
Beyond Compliance: NetraMark's Joseph Geraci, PhD, on Making AI-Driven Patient Subgroups Explainable
3
What This Study Means for Sponsors Still Struggling to Justify RBQM at Scale
4
ACT Brief: RBQM Multi-Functional Buy-In and E6(R3), Site Payment Performance and Cash Runway, and Inhaled Therapy for Cystic Fibrosis
5